Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...

Among children with exacerbation-prone asthma receiving placebo vs. mepolizumab, a significant link emerged between greater ...

Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, ...

Proton pump inhibitor (PPI) use in patients with chronic obstructive airway diseases is associated with an increased exacerbation risk.

GLP-1 initiation is associated with a 14.6% reduced risk of asthma exacerbation for overweight patients, 12.2% for obese patients and 13.3% for morbidly obese patients ...

For this study, outcomes were compared between 2 groups of patients with myasthenia gravis: those who developed exacerbations and those who did not experience exacerbations. Higher health care costs ...

Comorbidities and older age increase the risk of severe COVID-19 in MG patients, but not susceptibility to infection. MG treatments, including corticosteroids and immunosuppressants, do not heighten ...

Only 15% of patients were adherent to ICS therapy 3 months after their asthma exacerbation, and less that one-fourth of those remained adherent 9 months later. Improved adherence to inhaled ...

Acute exacerbations of idiopathic interstitial pneumonia (IIP) were associated with lower survival in adults with advanced lung cancer who underwent chemotherapy. Previous research suggests worse ...